Heart Fail Clin. 2023 Apr;19(2):205-211. doi: 10.1016/j.hfc.2022.08.003.
ABSTRACT
Despite aggressive care, patients with cardiopulmonary failure and COVID-19 experience unacceptably high mortality rates. The use of mechanical circulatory support devices in this population offers potential benefits but confers significant morbidity and novel challenges for the clinician. Thoughtful application of this complex technology is of the utmost importance and should be done in a multidisciplinary fashion by teams familiar with mechanical support devices and aware of the particular challenges provided by this complex patient population.
PMID:36863812 | DOI:10.1016/j.hfc.2022.08.003